Long-term resource use patterns and healthcare costs after myocardial infarction in a clinical practice setting: results from a contemporary nationwide registry study
Open Access
- 10 May 2016
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care & Clinical Outcomes
- Vol. 2 (4), 291-298
- https://doi.org/10.1093/ehjqcco/qcw019
Abstract
Long-term contemporary nationwide data on resource use and healthcare costs after myocardial infarction (MI) in a clinical practice setting are not widely studied, and the aim of this study was to investigate resource use patterns and healthcare costs in patients with MI in a nationwide clinical practice setting. This retrospective cohort study included all patients identified in the compulsory Swedish nationwide patient register with a diagnosis of MI between 1 July 2006 and 30 June 2011. Cardiovascular hospitalization and outpatient visits data from the patient register were combined with data from the cause of death register and the drug utilization register. For a subset of patients, data were also available from a primary care register. Healthcare resource use patterns and annual costs [reported in 2014 euros (€) converted from Swedish kronor (SEK) using the exchange rate €1 = SEK 9.33)] were estimated for the year prior to the occurrence of MI as well as for a maximum follow-up period of 6 years post-MI. The study included 97 252 patients with a diagnosis of MI with a total number of 285 351 observation years. The majority of healthcare consumption occurred within the first year of MI where patients were on average hospitalized 1.55 times, made 1.08 outpatient care visits, and 3.80 primary care visits. In the long term, for the majority of resource use categories, average consumption was higher in the years after MI compared with the year prior to MI. Healthcare costs at 6 years of follow-up were approximately €20 000 of which €12 460 occurred in the first year, and the major part was attributed to hospitalizations. For patients with 6 years of follow-up after MI, healthcare costs were approximately €20 000. The major part of costs occurred in the first year after MI and was driven by hospitalizations. NCT01984307.Funding Information
- AstraZeneca
This publication has 6 references indexed in Scilit:
- Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspectiveEuropean Heart Journal, 2015
- Cardiovascular disease in Europe: epidemiological updateEuropean Heart Journal, 2013
- Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980–2009European Heart Journal, 2013
- Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO studyEuropean Heart Journal, 2012
- Automated data extraction—A feasible way to construct patient registers of primary care utilizationUpsala Journal of Medical Sciences, 2012
- Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary InterventionCirculation, 2010